Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study

Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study

Abstract Objective Our previous metabolomics study showed that the plasma nervonic acid levels were higher in patients with major depressive disorder (MDD) than those in healthy controls and patients with bipolar disorder (BD). To examine whether the nervonic acid levels differ in the central nervou...

Full description

Bibliographic Details
Main Authors: Yuki Kageyama, Yasuhiko Deguchi, Kotaro Hattori, Sumiko Yoshida, Yu‐ichi Goto, Koki Inoue, Tadafumi Kato
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Brain and Behavior
Subjects:
biomarker
bipolar disorder
cerebrospinal fluid
major depressive disorder
nervonic acid
Online Access:https://doi.org/10.1002/brb3.2075

Similar Items

Similar Items